RankingsPricing
  1. US-listed companies
  2. Amphastar Pharmaceuticals, Inc.
  3. Financials
  4. Operating margin (%)

Amphastar Pharmaceuticals, Inc.AMPH

Market cap
$1.3B
P/E ratio
SummaryFinancials
Period EndOperating margin (%) YoY (%)
Dec 31, 202428.1-8.20%
Dec 31, 202330.6+41.90%
Dec 31, 202221.5+34.94%
Dec 31, 202116+409.87%
Dec 31, 20203.1-25980.24%
Dec 31, 2019-0-99.59%
Dec 31, 2018-2.9+685.30%
Dec 31, 2017-0.4-106.06%
Dec 31, 20166.1-324.24%
Dec 31, 2015-2.7-67.90%
Dec 31, 2014-8.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)